BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Leoni S, Tovoli F, Napoli L, Serio I, Ferri S, Bolondi L. Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis. World J Gastroenterol 2018; 24(30): 3361-3373 [PMID: 30122876 DOI: 10.3748/wjg.v24.i30.3361]
URL: https://www.wjgnet.com/1948-5182/full/v24/i30/3361.htm
Number Citing Articles
1
Ludovico Abenavoli, Luigi Boccuto, Alessandro Federico, Marcello Dallio, Carmelina Loguercio, Laura Di Renzo, Antonino De Lorenzo. Diet and Non-Alcoholic Fatty Liver Disease: The Mediterranean WayInternational Journal of Environmental Research and Public Health 2019; 16(17): 3011 doi: 10.3390/ijerph16173011
2
Ridhi Deo, Suranjan Panigrahi. Explainability Analysis of Black Box SVM models for Hepatic Steatosis Screening2022 IEEE Healthcare Innovations and Point of Care Technologies (HI-POCT) 2022; : 22 doi: 10.1109/HI-POCT54491.2022.9744067
3
Khara Lucius. Nutritional and Botanical Approaches for Nonalcoholic Fatty Liver DiseaseAlternative and Complementary Therapies 2020; 26(6): 246 doi: 10.1089/act.2020.29303.klu
4
Yejin Kim, Yoosoo Chang, Min-Jung Kwon, Yun Soo Hong, Mi Kyung Kim, Won Sohn, Yong Kyun Cho, Hocheol Shin, Sarah H. Wild, Christopher D. Byrne, Seungho Ryu. Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic AdultsAmerican Journal of Gastroenterology 2021; 116(11): 2270 doi: 10.14309/ajg.0000000000001344
5
Ahmed Hashem, Yogesh Shastri, Malfi Al Otaibi, Elwin Buchel, Hussam Saleh, Reyaz Ahmad, Hamouda Ahmed, Fateh Al Idris, Saleh Ahmed, Mohamed Guda, Anton Gillessen. Expert Opinion on the Management of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Middle East with a Focus on the Use of SilymarinGastroenterology Insights 2021; 12(2): 155 doi: 10.3390/gastroent12020014
6
Arshad Mehmood, Lei Zhao, Yong Wang, Fei Pan, Shuai Hao, Huimin Zhang, Asra Iftikhar, Muhammad Usman. Dietary anthocyanins as potential natural modulators for the prevention and treatment of non-alcoholic fatty liver disease: A comprehensive reviewFood Research International 2021; 142: 110180 doi: 10.1016/j.foodres.2021.110180
7
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!Metabolism 2019; 101: 154001 doi: 10.1016/j.metabol.2019.154001
8
Erenie Guirguis, Yasmin Grace, Anthony Bolson, Matthew J. DellaVecchia, Melissa Ruble. Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic reviewPharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 2021; 41(3): 315 doi: 10.1002/phar.2489
9
Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Irene Suarez-Pereira, Paula Iruzubieta, María Teresa Arias-Loste, Esther Setién-Suero, Rosa Ayesa-Arriola, Marcos Gómez-Revuelta, Javier Crespo, Benedicto Crespo Facorro. Data regarding the effect of cannabis consumption on liver function in the prospective PAFIP cohort of first episode psychosisData in Brief 2019; 27: 104415 doi: 10.1016/j.dib.2019.104415
10
Fangfei Xie, Yuyu Pei, Quan Zhou, Deli Cao, Yun Wang. Comparison of obesity-related indices for identifying nonalcoholic fatty liver disease: a population-based cross-sectional study in ChinaLipids in Health and Disease 2021; 20(1) doi: 10.1186/s12944-021-01560-3
11
Chanh-Phong Tran, John J Kim, Jordan J Feld, William WL Wong. Cost-effectiveness of obeticholic acid for the treatment of non-alcoholic steatohepatitis: An early economic evaluationCanadian Liver Journal 2021; 4(4): 360 doi: 10.3138/canlivj-2021-0011
12
Shuangzhen Jia, Yuzhen Zhao, Jiaqi Liu, Xu Guo, Moxian Chen, Shaoming Zhou, Jianli Zhou. Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic AccuracyFrontiers in Pediatrics 2022; 9 doi: 10.3389/fped.2021.784221
13
Francesco Tovoli, Silvia Ferri, Fabio Piscaglia. Hepatocellular Carcinoma in Non Alcoholic Fatty Liver DiseaseCurrent Pharmaceutical Design 2020; 26(32): 3909 doi: 10.2174/1381612826666200429093648
14
Yang Xia, Limin Cao, Qing Zhang, Li Liu, Shunming Zhang, Ge Meng, Hongmei Wu, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Adherence to a vegetable dietary pattern attenuates the risk of non‐alcoholic fatty liver disease in incident type 2 diabetes: The TCLSIH cohort studyJournal of Internal Medicine 2022; 291(4): 469 doi: 10.1111/joim.13428
15
Xiaoyan Li, Hua Wang. Multiple organs involved in the pathogenesis of non-alcoholic fatty liver diseaseCell & Bioscience 2020; 10(1) doi: 10.1186/s13578-020-00507-y
16
Ruojia Ma, Yike Zhan, Yamei Zhang, Liangan Wu, Xing Wang, Ming Guo. Schisandrin B ameliorates non‐alcoholic liver disease through anti‐inflammation activation in diabetic miceDrug Development Research 2021;  doi: 10.1002/ddr.21905
17
Inês H. Vieira, Luísa M. Barros, Carla F. Baptista, Dírcea M. Rodrigues, Isabel M. Paiva. Recommendations for Practical Use of Metformin, a Central Pharmacological Therapy in Type 2 DiabetesClinical Diabetes 2022; 40(1): 97 doi: 10.2337/cd21-0043
18
Jörn M Schattenberg, Quentin M Anstee, Cyrielle Caussy, Elisabetta Bugianesi, Branko Popovic. Differences between current clinical guidelines for screening, diagnosis and management of nonalcoholic fatty liver disease and real-world practice: a targeted literature reviewExpert Review of Gastroenterology & Hepatology 2021; 15(11): 1253 doi: 10.1080/17474124.2021.1974295
19
Dominic S. Ng. Emerging insight into the role of cellular cholesterol in the pathogenesis of nonalcoholic steatohepatitis progressionCurrent Opinion in Lipidology 2020; 31(4): 262 doi: 10.1097/MOL.0000000000000693
20
Banshi Saboo, Sanjay Agarwal, Brij Mohan Makkar, Rajeev Chawla, Sujoy Ghosh, Vijay Viswanathan, Sunil Gupta, Ch. Vasanth Kumar, Anuj Maheshwari, L. Sreenivasamurthy, Rakesh Kumar Sahay, Sanjay Reddy, Shalini Jaggi, Jugal Kishor Sharma, Vijay Panikar, Anand Moses, Bikash Bhattacharjee, Pratap Jethwani, Sudhir Bhandari, J. P. S. Sawhney, Shashank Joshi, Saumitra Ray, S. V. Madhu, Bipin Sethi. RSSDI consensus recommendations for dyslipidemia management in diabetes mellitusInternational Journal of Diabetes in Developing Countries 2022; 42(1): 3 doi: 10.1007/s13410-022-01063-6
21
Jonathan Mertens, Christophe De Block, Maarten Spinhoven, Ann Driessen, Sven M. Francque, Wilhelmus J. Kwanten. Hepatopathy Associated With Type 1 Diabetes: Distinguishing Non-alcoholic Fatty Liver Disease From Glycogenic HepatopathyFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.768576
22
Yang Xia, Shunming Zhang, Qing Zhang, Li Liu, Ge Meng, Hongmei Wu, Xue Bao, Yeqing Gu, Shaomei Sun, Xing Wang, Ming Zhou, Qiyu Jia, Kun Song, Qijun Wu, Kaijun Niu, Yuhong Zhao. Insoluble dietary fibre intake is associated with lower prevalence of newly-diagnosed non-alcoholic fatty liver disease in Chinese men: a large population-based cross-sectional studyNutrition & Metabolism 2020; 17(1) doi: 10.1186/s12986-019-0420-1
23
Rodrigo Valenzuela, Luis A. Videla. Impact of the Co-Administration of N-3 Fatty Acids and Olive Oil Components in Preclinical Nonalcoholic Fatty Liver Disease Models: A Mechanistic ViewNutrients 2020; 12(2): 499 doi: 10.3390/nu12020499
24
Harold E. Bays, Amit Khera, Michael J. Blaha, Matthew J Budoff, Peter P. Toth. Ten things to know about ten imaging studies: A preventive cardiology perspective (“ASPC top ten imaging”)American Journal of Preventive Cardiology 2021; 6: 100176 doi: 10.1016/j.ajpc.2021.100176
25
Natalia O. Nosko, Viacheslav V. Kharchenko. INSULIN RESISTANCE AS AN INDICATOR OF DIFFERENTIATION FOR THE FORMATION OF RISK GROUPS FOR NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITHOUT TYPE 2 DIABETES MELLITUS, AS A PART OF ONTOLOGICAL MODEL OF NON-ALCOHOLIC FATTY LIVER DISEASEWiadomości Lekarskie 2021; 74(10): 2593 doi: 10.36740/WLek202110212
26
Anne M. Misher, Jennifer L. Rosselli, Christine A. Schumacher, Michael See. The Role of the Diabetes Care and Education Specialist in Caring for Diabetes Complications and Common Comorbid ConditionsADCES in Practice 2021; 9(3): 30 doi: 10.1177/2633559X211002805
27
Josephine Skat-Rørdam, Kamilla Pedersen, Gry Freja Skovsted, Ida Gregersen, Sara Vangsgaard, David H. Ipsen, Markus Latta, Jens Lykkesfeldt, Pernille Tveden-Nyborg. Vitamin C Deficiency May Delay Diet-Induced NASH Regression in the Guinea PigAntioxidants 2021; 11(1): 69 doi: 10.3390/antiox11010069
28
Zeinab El Rashed, Elena Grasselli, Hala Khalifeh, Laura Canesi, Ilaria Demori. Brown-Algae Polysaccharides as Active Constituents against Nonalcoholic Fatty Liver DiseasePlanta Medica 2022; 88(01): 9 doi: 10.1055/a-1273-3159
29
Swastika Maity, Jaya Aakriti, Suman Manandhar, Sharad B Anchan, Ashlesh Bhat, Mayur U Shetty, Yogendra Nayak. Emvolio - A battery operated portable refrigerator preserves biochemical and haematological integrity of biological samples in preclinical studiesF1000Research 2022; 11: 223 doi: 10.12688/f1000research.109134.1
30
Martin M. Grajower. Nonalcoholic SteatohepatitisJAMA 2020; 324(9): 899 doi: 10.1001/jama.2020.10434
31
Marco Arrese, Francisco Barrera, Nicolas Triantafilo, Juan Pablo Arab. Concurrent nonalcoholic fatty liver disease and type 2 diabetes: diagnostic and therapeutic considerationsExpert Review of Gastroenterology & Hepatology 2019; 13(9): 849 doi: 10.1080/17474124.2019.1649981
32
T. N. Alexandrova, O. Ya. Babak . Effects of Ademetionine on Liver Fibrosis, Level of Pentraxin-3 and Metabolic Indicators in Patients with Comorbid Course of Non-alcoholic Liver Disease and Arterial HypertensionUkraïnsʹkij žurnal medicini, bìologìï ta sportu 2020; 5(6): 95 doi: 10.26693/jmbs05.06.095
33
Chayanis Kositamongkol, Sukrit Kanchanasurakit, Chiraphong Auttamalang, Nutkamon Inchai, Thanatchaporn Kabkaew, Sarunporn Kitpark, Nathorn Chaiyakunapruk, Acharaporn Duangjai, Surasak Saokaew, Pochamana Phisalprapa. Coffee Consumption and Non-alcoholic Fatty Liver Disease: An Umbrella Review and a Systematic Review and Meta-analysisFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.786596
34
David Hermanus Wessels, Zeil Rosenberg. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?World Journal of Hepatology 2021; 13(2): 233-241 doi: 10.4254/wjh.v13.i2.233
35
Sina Ghandian, Rahul Thapa, Anurag Garikipati, Gina Barnes, Abigail Green‐Saxena, Jacob Calvert, Qingqing Mao, Ritankar Das. Machine learning to predict progression of non‐alcoholic fatty liver to non‐alcoholic steatohepatitis or fibrosisJGH Open 2022; 6(3): 196 doi: 10.1002/jgh3.12716
36
Yang Xia, Qijun Wu, Huixu Dai, Jiale Lv, Yashu Liu, Hui Sun, Yuting Jiang, Qing Chang, Kaijun Niu, Yuhong Zhao. Associations of Nutritional, Lifestyle, and Metabolic Factors With Non-alcoholic Fatty Liver Disease: An Umbrella Review With More Than 380,000 ParticipantsFrontiers in Nutrition 2021; 8 doi: 10.3389/fnut.2021.642509
37
Kamil Synoradzki, Paweł Grieb. Citicoline: A Superior Form of Choline?Nutrients 2019; 11(7): 1569 doi: 10.3390/nu11071569
38
Zhuo Wei, Dan Zhao, Ye Zhang, Yuanli Chen, Shuang Zhang, Qi Li, Peng Zeng, Xiaoju Li, Wenwen Zhang, Yajun Duan, Jihong Han, Xiaoxiao Yang. Rosiglitazone ameliorates bile duct ligation-induced liver fibrosis by down-regulating NF-κB-TNF-α signaling pathway in a PPARγ-dependent mannerBiochemical and Biophysical Research Communications 2019; 519(4): 854 doi: 10.1016/j.bbrc.2019.09.084
39
Jae-Hyung Roh, Hanbyul Lee, Bae Yun-Jeong, Chan Sun Park, Hyo-Jung Kim, Sun-Young Yoon, Huei-Kai Huang. A nationwide survey of the association between nonalcoholic fatty liver disease and the incidence of asthma in Korean adultsPLOS ONE 2022; 17(1): e0262715 doi: 10.1371/journal.pone.0262715
40
Joana Rigor, Andreia Diegues, José Presa, Pedro Barata, Daniela Martins-Mendes. Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese populationPostgraduate Medicine 2022; : 1 doi: 10.1080/00325481.2022.2058285
41
Mahboobe Hosseinikia, Farhad Oubari, Roghaye Hosseinkia, Zibaneh Tabeshfar, Mohammad Gharib Salehi, Zeinab Mousavian, Mehrnaz Abbasi, Mehnoosh Samadi, Yahya Pasdar. Quercetin supplementation in non-alcoholic fatty liver diseaseNutrition & Food Science 2020; 50(6): 1279 doi: 10.1108/NFS-10-2019-0321
42
Chia-Chi Wang, Pin-Nan Cheng, Jia-Horng Kao. Systematic review: chronic viral hepatitis and metabolic derangementAlimentary Pharmacology & Therapeutics 2020; 51(2): 216 doi: 10.1111/apt.15575
43
Di Cao, Mengyi Li, Yang Liu, He Jin, Dawei Yang, Hui Xu, Han Lv, JIa Liu, Peng Zhang, Zhongtao Zhang, Zhenghan Yang. Comparison of reader agreement, correlation with liver biopsy, and time-burden sampling strategies for liver proton density fat fraction measured using magnetic resonance imaging in patients with obesity: a secondary cross-sectional studyBMC Medical Imaging 2022; 22(1) doi: 10.1186/s12880-022-00821-6
44
Farah D.R. Al-Baiaty, Aziana Ismail, Zarina Abdul Latiff, Khairul Najmi Muhammad Nawawi, Raja Affendi Raja Ali, Norfilza Mohd Mokhtar. Possible Hepatoprotective Effect of Tocotrienol-Rich Fraction Vitamin E in Non-alcoholic Fatty Liver Disease in Obese Children and AdolescentsFrontiers in Pediatrics 2021; 9 doi: 10.3389/fped.2021.667247
45
John A. Dougherty, Erenie Guirguis, Krisy-Ann Thornby. A Systematic Review of Newer Antidiabetic Agents in the Treatment of Nonalcoholic Fatty Liver DiseaseAnnals of Pharmacotherapy 2021; 55(1): 65 doi: 10.1177/1060028020935105
46
Mary P. Moore, Rory P. Cunningham, Rachel A. H. Davis, Sarah E. Deemer, Brandon M. Roberts, Eric P. Plaisance, R. Scott Rector. A dietary ketone ester mitigates histological outcomes of NAFLD and markers of fibrosis in high-fat diet fed miceAmerican Journal of Physiology-Gastrointestinal and Liver Physiology 2021; 320(4): G564 doi: 10.1152/ajpgi.00259.2020
47
Anne Maiden, Shannon Scott, Erin Raney, Marisa Strobridge. Nonalcoholic Steatohepatitis: Case-Based Focused on Pediatric and Adult GuidelinesOsteopathic Family Physician 2021; : 29 doi: 10.33181/13024
48
Lu Zhong, Xiaojuan Peng, Chutian Wu, Qing Li, Yanfang Chen, Min Wang, Yuting Li, Kaiyin He, Ying Shi, Caiqun Bie, Shaohui Tang. Polysaccharides and flavonoids from cyclocarya paliurus modulate gut microbiota and attenuate hepatic steatosis, hyperglycemia, and hyperlipidemia in nonalcoholic fatty liver disease rats with type 2 diabetes mellitusInternational Journal of Diabetes in Developing Countries 2022;  doi: 10.1007/s13410-022-01080-5
49
Amedeo Lonardo, Stefano Ballestri. Perspectives of nonalcoholic fatty liver disease research: a personal point of viewExploration of Medicine 2020; 1(3): 85 doi: 10.37349/emed.2020.00007
50
Yuichiro Eguchi, Gabriel Wong, Omar Akhtar, Yoshio Sumida. Non‐invasive diagnosis of non‐alcoholic steatohepatitis and advanced fibrosis in Japan: A targeted literature reviewHepatology Research 2020; 50(6): 645 doi: 10.1111/hepr.13502
51
Karolina Grąt, Michał Grąt, Olgierd Rowiński. Usefulness of Different Imaging Modalities in Evaluation of Patients with Non-Alcoholic Fatty Liver DiseaseBiomedicines 2020; 8(9): 298 doi: 10.3390/biomedicines8090298
52
Eric R. Yoo, Donghee Kim, Luis M. Vazquez‐Montesino, Jessica A. Escober, Andrew A. Li, Sean P. Tighe, Christopher T. Fernandes, George Cholankeril, Aijaz Ahmed. Diet quality and its association with nonalcoholic fatty liver disease and all‐cause and cause‐specific mortalityLiver International 2020; 40(4): 815 doi: 10.1111/liv.14374
53
Chiara Zusi, Alessandro Mantovani, Francesca Olivieri, Anita Morandi, Massimiliano Corradi, Emanuele Miraglia Del Giudice, Marco Dauriz, Luca Valenti, Christopher D. Byrne, Giovanni Targher, Claudio Maffeis. Contribution of a genetic risk score to clinical prediction of hepatic steatosis in obese children and adolescentsDigestive and Liver Disease 2019; 51(11): 1586 doi: 10.1016/j.dld.2019.05.029
54
Mercedes Perez-Carreras, Begoña Casis-Herce, Raquel Rivera, Inmaculada Fernandez, Pilar Martinez-Montiel, Victoria Villena. Non-alcoholic fatty liver disease in patients with intestinal, pulmonary or skin diseases: Inflammatory cross-talk that needs a multidisciplinary approachWorld Journal of Gastroenterology 2021; 27(41): 7113-7124 doi: 10.3748/wjg.v27.i41.7113
55
Tongxi Zhuang, Wei Li, Li Yang, Zhengtao Wang, Lili Ding, Mingmei Zhou. Gut Microbiota: Novel Therapeutic Target of Ginsenosides for the Treatment of Obesity and Its ComplicationsFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.731288
56
Amedeo Lonardo, Simona Leoni, Khalid A. Alswat, Yasser Fouad. History of Nonalcoholic Fatty Liver DiseaseInternational Journal of Molecular Sciences 2020; 21(16): 5888 doi: 10.3390/ijms21165888
57
Fangfei Xie, Hong Zhou, Yun Wang. Atherogenic index of plasma is a novel and strong predictor associated with fatty liver: a cross-sectional study in the Chinese Han populationLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1112-6
58
Stefano Ciardullo, Tommaso Monti, Gianluca Perseghin. Lack of awareness of liver organ damage in patients with type 2 diabetesActa Diabetologica 2021; 58(5): 651 doi: 10.1007/s00592-021-01677-y
59
David J. Hanna, Scott T. Jamieson, Christine S. Lee, Christopher A. Pluskota, Nicole J. Bressler, Peter N. Benotti, Sandeep Khurana, David D. K. Rolston, Christopher D. Still. “Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”Obesity Science & Practice 2021; 7(5): 629 doi: 10.1002/osp4.509
60
Jean-François Dufour, Roger Scherer, Maria-Magdalena Balp, Sarah Jane McKenna, Nico Janssens, Patricia Lopez, Marcos Pedrosa. The global epidemiology of nonalcoholic steatohepatitis (NASH) and associated risk factors–A targeted literature reviewEndocrine and Metabolic Science 2021; 3: 100089 doi: 10.1016/j.endmts.2021.100089
61
Alberto Enrico Maraolo, Antonio Riccardo Buonomo, Emanuela Zappulo, Riccardo Scotto, Biagio Pinchera, Ivan Gentile. Unsolved Issues in the Treatment of Spontaneous Peritonitis in Patients with Cirrhosis: Nosocomial Versus Community-acquired Infections and the Role of FungiReviews on Recent Clinical Trials 2019; 14(2): 129 doi: 10.2174/1574887114666181204102516
62
Yuxiu Liu, Shiying Liu, Jiaofeng Huang, Yueyong Zhu, Su Lin. Validation of five hepatic steatosis algorithms in metabolic‐associated fatty liver disease: A population based studyJournal of Gastroenterology and Hepatology 2022; 37(5): 938 doi: 10.1111/jgh.15799
63
Tsung-Hsien Chou, Hsing-Jung Yeh, Chun-Chao Chang, Jui-Hsiang Tang, Wei-Yu Kao, I-Chia Su, Chien-Hung Li, Wei-Hao Chang, Chun-Kai Huang, Herdiantri Sufriyana, Emily Chia-Yu Su. Deep learning for abdominal ultrasound: A computer-aided diagnostic system for the severity of fatty liverJournal of the Chinese Medical Association 2021; 84(9): 842 doi: 10.1097/JCMA.0000000000000585
64
Jeffrey V. Lazarus, Henry E. Mark, Quentin M. Anstee, Juan Pablo Arab, Rachel L. Batterham, Laurent Castera, Helena Cortez-Pinto, Javier Crespo, Kenneth Cusi, M. Ashworth Dirac, Sven Francque, Jacob George, Hannes Hagström, Terry T.-K. Huang, Mona H. Ismail, Achim Kautz, Shiv Kumar Sarin, Rohit Loomba, Veronica Miller, Philip N. Newsome, Michael Ninburg, Ponsiano Ocama, Vlad Ratziu, Mary Rinella, Diana Romero, Manuel Romero-Gómez, Jörn M. Schattenberg, Emmanuel A. Tsochatzis, Luca Valenti, Vincent Wai-Sun Wong, Yusuf Yilmaz, Zobair M. Younossi, Shira Zelber-Sagi, Fredrik Åberg, Leon Adams, Maryam Salem Al Khatry, Khalid Al Naamani, Omar Alfaro Murillo, Alina M. Allen, Faisal Alnaser, Saleh A. Alqahtani, Khalid Alswat, Domenico Alvaro, Raúl J. Andrade, Marco Arrese, Yaw Asante Awuku, Motala Ayesha, Oidov Baatarkhuu, Shokhista Bakieva, Rita Basu, Ramon Bataller, Shahinaz Bedri, Emanuele Bosi, Marc Bourliere, Radan Bruha, Elisabetta Bugianesi, Patrizia Burra, Maria Buti, Christopher D. Byrne, Jose Luis Calleja, Patrizia Carrieri, Flloyd Carter, Marlen Ivon Castellanos Fernandez, Gabriela Castillo-Lopez, Graciela E. Castro-Narro, Henry Lik Yuen Chan, Wah-Kheong Chan, Yoosoo Chang, Massimo Colombo, Kirsten J. Coppell, Kathleen Corey, Antonio Craxi, Donna Cryer, Anuradha Dassanayake, Antonieta de Ascenção Soares Martins, Victor de Ledinghen, Stefano DelPrato, Alessandro Demaio, Hailemichael Desalegn, John Dillon, Ajay Duseja, Prabhakaran Dorairaj, Mattias Ekstedt, Mohamed El Kassas, Osama M. Elsanousi, Gamal Esmat, Jian-Gao Fan, Nathalie Farpour-Lambert, Robert Flisiak, Yasser Fouad, Michael Fuchs, Rino A. Gani, Lynn Gerber, Hasmik Ghazinyan, Liana Gheorghe, George Boon-Bee Goh, Henning Grønbæk, Aghayeva Gulnara, Saeed Hamid, Vanessa Hebditch, Ingrid J. Hickman, Samantha L. Hocking, Bela Hunyady, Ramazan Idilman, Vasily A. Isakov, Mohammad H. Jamal, Peter Jepsen, Natacha Jreige Iskandar, Myeong Jun Song, K. C. Sudhamshu, Satoru Kakizaki, George Kalamitsis, Fasiha Kanwal, Jia-Horng Kao, Lee Kaplan, Takumi Kawaguchi, Yousef Khader, Seung Up Kim, Nicolas Kodjoh, Ger Koek, Kazuhiko Koike, Narcisse Patrice Komas, Marko Korenjak, Marcelo Kugelmas, Asma Labidi, Naomi F. Lange, Joel E. Lavine, Mariana Lazo, Nancy Lee, Cosmas Rinaldi A. Lesmana, Chun-Jen Liu, Michelle T. Long, Patricio Lopez-Jaramillo, Reza Malekzadeh, Mamun Al Mahtab, Giulio Marchesini, Rui Marinho, Sophia E. Martínez Vázquez, Lyudmila Mateva, Charles Mbendi Nlombi, Pascal Melin, Ivana Mikolasevic, Tamara Milovanovic, Carla Musso, Atsushi Nakajima, Edna Nava, Alexander V. Nersesov, Dafina Nikolova, Suzanne Norris, Katja Novak, Jude Oben, Janus P. Ong, Charles Onyekwere, George Papatheodoridis, Imran Paruk, Keyur Patel, M. Paula Macedo, Carlos Penha-Gonçalves, Marlene Pérez Figueroa, Wolf Peter Hofmann, Salvatore Petta, Claudia Pinto Marques Souza de Oliveira, Puneet Puri, Calvin Q. Pan, Marek Rac, Johanna Ralston, Alnoor Ramji, Homie Razavi, Mario Reis Alvares-da-Silva, Stuart Roberts, Michael Roden, Tamsin Rose, Samir Rouabhia, Patrizia Rovere-Querini, Ian A. Rowe, Shakhlo Sadirova, Riina Salupere, Tobokalova Saparbu, Raymond Sayegh, Giada Sebastiani, Yosuke Seki, Josefina Selmo, Abdel Karim Serme, Jonathan E. Shaw, Thrivikrama Shenoy, Nick Sheron, Oren Shibolet, Marcelo Silva, Igor Skrypnyk, Piotr Socha, Joan Soriano, C. Wendy Spearman, Kannan Sridharan, Juan José Suárez, Dhastagir Sultan Sheriff, Ki-Chul Sung, Mark Swain, Frank Tacke, Shahrad Taheri, Soek-Siam Tan, Elliot B. Tapper, Hannele Yki-Järvinen, Maja Thiele, Isaac Thom Shawa, Ieva Tolmane, Esther A. Torres, Michael Trauner, Sombat Treeprasertsuk, Adela Turcanu, Jonas Valantinas, Mette Vesterhus, Imam Waked, Sarah H. Wild, Jose Willemse, Robert J. Wong, Stavra Xanthakos, Dan Yock Young, Ming-Lung Yu, Kenneth I. Zheng, Mudjat Zeybel, Ming-Hua Zheng. Advancing the global public health agenda for NAFLD: a consensus statementNature Reviews Gastroenterology & Hepatology 2022; 19(1): 60 doi: 10.1038/s41575-021-00523-4
65
Ewa Garbiec, Judyta Cielecka-Piontek, Magdalena Kowalówka, Magdalena Hołubiec, Przemysław Zalewski. Genistein—Opportunities Related to an Interesting Molecule of Natural OriginMolecules 2022; 27(3): 815 doi: 10.3390/molecules27030815
66
Halyna Kuznietsova, Oksana Lynchak, Natalia Dziubenko, Tetyana Herheliuk, Yuriy Prylutskyy, Volodymyr Rybalchenko, Uwe Ritter. Water-soluble pristine C60 fullerene attenuates acetaminophen-induced liver injuryBioImpacts 2019; 9(4): 227 doi: 10.15171/bi.2019.28
67
Ting-Yu Chen, Ya-Ling Chen, Wan-Chun Chiu, Chiu-Li Yeh, Yu-Tang Tung, Hitoshi Shirakawa, Wei-Tzu Liao, Suh-Ching Yang. Effects of the Water Extract of Fermented Rice Bran on Liver Damage and Intestinal Injury in Aged Rats with High-Fat Diet FeedingPlants 2022; 11(5): 607 doi: 10.3390/plants11050607
68
Kiarash Riazi, Maitreyi Raman, Lorian Taylor, Mark G. Swain, Abdel Aziz Shaheen. Dietary Patterns and Components in Nonalcoholic Fatty Liver Disease (NAFLD): What Key Messages Can Health Care Providers Offer?Nutrients 2019; 11(12): 2878 doi: 10.3390/nu11122878
69
Rebecca Sewter, Susan Heaney, Amanda Patterson. Coffee Consumption and the Progression of NAFLD: A Systematic ReviewNutrients 2021; 13(7): 2381 doi: 10.3390/nu13072381
70
Mélanie Maltais, Diane Brisson, Daniel Gaudet. Non-Alcoholic Fatty Liver in Patients with ChylomicronemiaJournal of Clinical Medicine 2021; 10(4): 669 doi: 10.3390/jcm10040669
71
Suranjan Panigrahi, Ridhi Deo, Edward A. Liechty. A New Machine Learning-Based Complementary Approach for Screening of NAFLD (Hepatic Steatosis)2021 43rd Annual International Conference of the IEEE Engineering in Medicine & Biology Society (EMBC) 2021; : 2343 doi: 10.1109/EMBC46164.2021.9629507
72
Hannah Drescher, Sabine Weiskirchen, Ralf Weiskirchen. Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH)Cells 2019; 8(8): 845 doi: 10.3390/cells8080845
73
Patrick T. Campbell, Lisa B. VanWagner, Laura A. Colangelo, Cora E. Lewis, Anne Henkel, Veeral H. Ajmera, Donald M. Lloyd‐Jones, Douglas E. Vaughan, Sadiya S. Khan. Association between plasminogen activator inhibitor‐1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIALiver International 2020; 40(5): 1111 doi: 10.1111/liv.14417
74
Zoran Gluvic, Ratko Tomasevic, Ksenija Bojovic, Milan Obradovic, Esma R. Isenovic. Non-alcoholic fatty liver disease: a multidisciplinary clinical practice approach—the institutional adaptation to existing Clinical Practice GuidelinesEmergency and Critical Care Medicine 2022; 2(1): 12 doi: 10.1097/EC9.0000000000000016
75
Renata Risi, Rossella Tozzi, Mikiko Watanabe. Beyond weight loss in nonalcoholic fatty liver disease: the role of carbohydrate restrictionCurrent Opinion in Clinical Nutrition & Metabolic Care 2021; 24(4): 349 doi: 10.1097/MCO.0000000000000762
76
Joshua Tseng, Jeremy Korman, Mazen Noureddin, Daniel Shouhed, James P. Miller, Xiaoxi Feng, Miguel Burch. Routine Versus Selective Liver Biopsy During Bariatric Surgery: Postoperative Outcomes and Preoperative Predictors of NASHObesity Surgery 2022; 32(2): 463 doi: 10.1007/s11695-021-05797-w
77
Muhammad Masroor, Zeba Haque. HbA1C as a Biomarker of Non-alcoholic Fatty Liver Disease: Comparison with Anthropometric ParametersJournal of Clinical and Translational Hepatology 2021; 0(000): 1 doi: 10.14218/JCTH.2019.00046
78
Sandra A. Soto‐Alarcón, Macarena Ortiz, Paula Orellana, Francisca Echeverría, Andrés Bustamante, Alejandra Espinosa, Paola Illesca, Daniel Gonzalez‐Mañán, Rodrigo Valenzuela, Luis A. Videla. Docosahexaenoic acid and hydroxytyrosol co‐administration fully prevents liver steatosis and related parameters in mice subjected to high‐fat diet: A molecular approachBioFactors 2019; 45(6): 930 doi: 10.1002/biof.1556
79
Abdulrahman Ismaiel, Stefan-Lucian Popa, Dan L. Dumitrascu, Quirino Lai. Acute Coronary Syndromes and Nonalcoholic Fatty Liver Disease: “Un Affaire de Coeur”Canadian Journal of Gastroenterology and Hepatology 2020; 2020: 1 doi: 10.1155/2020/8825615
80
Stergios A. Polyzos, Dimitrios G. Goulis, Olga Giouleme, Georgios S. Germanidis, Antonis Goulas. Anti-obesity Medications for the Management of Nonalcoholic Fatty Liver DiseaseCurrent Obesity Reports 2022;  doi: 10.1007/s13679-022-00474-0
81
Helena Julià, David Benaiges, Juan Pedro-Botet. Bariatric surgery and non-alcoholic fatty liver diseaseMedicina Clínica 2022;  doi: 10.1016/j.medcli.2021.12.003
82
RehabF Abdel-Rahman. Non-alcoholic fatty liver disease: Epidemiology, pathophysiology and an update on the therapeutic approachesAsian Pacific Journal of Tropical Biomedicine 2022; 12(3): 99 doi: 10.4103/2221-1691.338919
83
Ricard Corcelles, Juan S. Barajas-Gamboa, Joana Ferrer-Fàbrega, Matthew Kroh. Cirugía bariátrica en trasplante hepático: tendencias actuales y perspectivas futurasCirugía Española 2022; 100(2): 59 doi: 10.1016/j.ciresp.2021.04.025
84
Ricard Corcelles, Juan S. Barajas-Gamboa, Joana Ferrer-Fàbrega, Matthew Kroh. Bariatric surgery in liver transplant: Current trends and future perspectivesCirugía Española (English Edition) 2022; 100(2): 59 doi: 10.1016/j.cireng.2021.04.021
85
Danyan Ma, Jinyang Zeng, Bingkun Huang, Fangfang Yan, Jiawen Ye, Yun Chen, Xiying Zeng, Xin Zheng, Fangsen Xiao, Mingzhu Lin, Changqin Liu, Zhibin Li. Independent associations of thyroid-related hormones with hepatic steatosis and insulin resistance in euthyroid overweight/obese Chinese adultsBMC Gastroenterology 2021; 21(1) doi: 10.1186/s12876-021-02011-0
86
Abdulrahman Ismaiel, Ayman Jaaouani, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. The Visceral Adiposity Index in Non-Alcoholic Fatty Liver Disease and Liver Fibrosis—Systematic Review and Meta-AnalysisBiomedicines 2021; 9(12): 1890 doi: 10.3390/biomedicines9121890
87
Ryoko Tajima, Fumiaki Imamura, Takeshi Kimura, Satomi Kobayashi, Katsunori Masuda, Kaoruko Iida. Association of alcohol consumption with prevalence of fatty liver after adjustment for dietary patterns: Cross-sectional analysis of Japanese middle-aged adultsClinical Nutrition 2020; 39(5): 1580 doi: 10.1016/j.clnu.2019.07.001
88
Kelly Casler, Amanda Chaney. CirrhosisNursing 2021; 51(2): 24 doi: 10.1097/01.NURSE.0000731828.24893.bb
89
Valentin Metzner, Gloria Herzog, Tobias Heckel, Thorsten Bischler, Julia Hasinger, Christoph Otto, Martin Fassnacht, Andreas Geier, Florian Seyfried, Ulrich Dischinger. Liraglutide + PYY3-36 Combination Therapy Mimics Effects of Roux-en-Y Bypass on Early NAFLD Whilst Lacking-Behind in Metabolic ImprovementsJournal of Clinical Medicine 2022; 11(3): 753 doi: 10.3390/jcm11030753
90
Leen J. M. Heyens, Dana Busschots, Ger H. Koek, Geert Robaeys, Sven Francque. Liver Fibrosis in Non-alcoholic Fatty Liver Disease: From Liver Biopsy to Non-invasive Biomarkers in Diagnosis and TreatmentFrontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.615978
91
Tiantian Song, Shuchun Chen, Hang Zhao, Fei Wang, Huan Song, Dongliang Tian, Qiwen Yang, Licui Qi. Meta‐analysis of the effect of sodium–glucose cotransporter 2 inhibitors on hepatic fibrosis in patients with type 2 diabetes mellitus complicated with non‐alcoholic fatty liver diseaseHepatology Research 2021; 51(6): 641 doi: 10.1111/hepr.13645
92
Hassan M. Heshmati. Advances in Hepatology2021;  doi: 10.5772/intechopen.97568
93
Hannah Collins, Grant Beban, John Windsor, Rishi Ram, David Orr, Nicholas Evennett, Benjamin Loveday. Safety and Utility of Liver Biopsy During Bariatric Surgery in the New Zealand SettingObesity Surgery 2020; 30(1): 313 doi: 10.1007/s11695-019-04161-3
94
D. V. Garbuzenko. Drug Therapy for Non-Alcoholic Steatohepatitis-Induced Liver FibrosisRussian Journal of Gastroenterology, Hepatology, Coloproctology 2022; 31(5): 16 doi: 10.22416/1382-4376-2021-31-5-16-24
95
Daniel Faurholt-Jepsen, Henrik Friis, David L. Mwaniki, Michael K. Boit, Lydia U. Kaduka, Inge Tetens, Dirk L. Christensen, Giacomo Pucci. Waist circumference and low high-density lipoprotein cholesterol as markers of cardiometabolic risk in Kenyan adultsPLOS ONE 2021; 16(2): e0247600 doi: 10.1371/journal.pone.0247600
96
Saber Ghiassi, Maher El Chaar, Essa M. Aleassa, Fady Moustarah, Sofiane El Djouzi, T. Javier Birriel, Ann M. Rogers. ASMBS position statement on the relationship between obesity and cancer, and the role of bariatric surgery: risk, timing of treatment, effects on disease biology, and qualification for surgerySurgery for Obesity and Related Diseases 2020; 16(6): 713 doi: 10.1016/j.soard.2020.03.019
97
Abdulrahman Ismaiel, Daniel-Corneliu Leucuta, Stefan-Lucian Popa, Dan L. Dumitrascu. Serum Visfatin Levels in Nonalcoholic Fatty Liver Disease and Liver Fibrosis: Systematic Review and Meta-AnalysisJournal of Clinical Medicine 2021; 10(14): 3029 doi: 10.3390/jcm10143029
98
Hao Han, Yan Guo, Xiaoyu Li, Dongxing Shi, Tingli Xue, Linqi Wang, Yanyan Li, Mingming Zheng. Plant Sterol Ester of α-Linolenic Acid Attenuates Nonalcoholic Fatty Liver Disease by Rescuing the Adaption to Endoplasmic Reticulum Stress and Enhancing Mitochondrial BiogenesisOxidative Medicine and Cellular Longevity 2019; 2019: 1 doi: 10.1155/2019/8294141
99
Mithun Sharma, Madhumita Premkumar, Anand V Kulkarni, Pramod Kumar, D Nageshwar Reddy, Nagaraja Padaki Rao. Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy GrailJournal of Clinical and Translational Hepatology 2020; 0(000): 1 doi: 10.14218/JCTH.2020.00055
100
Anouk Charlot, Joffrey Zoll. Beneficial Effects of the Ketogenic Diet in Metabolic Syndrome: A Systematic ReviewDiabetology 2022; 3(2): 292 doi: 10.3390/diabetology3020020
101
Eduardo Lemos De Souza Bastos, Almino Ramos Cardoso. The Perfect Sleeve Gastrectomy2020; : 19 doi: 10.1007/978-3-030-28936-2_3
102
MoezAlIslam Faris, Haitham Jahrami, Dana Abdelrahim, Nicola Bragazzi, Ahmed BaHammam. The effects of Ramadan intermittent fasting on liver function in healthy adults: A systematic review, meta-analysis, and meta-regressionDiabetes Research and Clinical Practice 2021; 178: 108951 doi: 10.1016/j.diabres.2021.108951
103
Kay Craven, Donna Clement, Caroline T. Brewster, Jamie Messenger, Kathryn M. Kolasa. Non-Alcoholic Fatty Liver Disease (NAFLD) and NutritionNutrition Today 2021; 56(6): 296 doi: 10.1097/NT.0000000000000514
104
Elena-Daniela Grigorescu, Mariana Floria, Cristina Mihaela Lăcătușu, Bogdan Mircea-Mihai, Ioana Creţu, Alina Delia Popa, Alina Onofriescu, Irina M. Jaba, Victoriţa Șorodoc, Alexandr Ceasovschih, Laurenţiu Șorodoc. The Relationship between Hepatic Steatosis, inflammation and insulin Resistance in type 2 Diabetes with Metabolic ImbalanceInternal Medicine 2019; 16(4): 13 doi: 10.2478/inmed-2019-0073
105
Qun Liu, Shousheng Liu, Lizhen Chen, Zhenzhen Zhao, Shuixian Du, Quanjiang Dong, Yongning Xin, Shiying Xuan. Role and effective therapeutic target of gut microbiota in NAFLD/NASH (Review)Experimental and Therapeutic Medicine 2019;  doi: 10.3892/etm.2019.7781
106
Gabriela Xavier Ortiz, Gabriele Lenhart, Matheus William Becker, Karin Hepp Schwambach, Cristiane Valle Tovo, Carine Raquel Blatt. Drug-induced liver injury and COVID-19: A review for clinical practiceWorld Journal of Hepatology 2021; 13(9): 1143-1153 doi: 10.4254/wjh.v13.i9.1143
107
Meng-Hsun Yu, Tung-Wei Hung, Chi-Chih Wang, Sheng-Wen Wu, Tzu-Wei Yang, Ching-Yu Yang, Tsui-Hwa Tseng, Chau-Jong Wang. Neochlorogenic Acid Attenuates Hepatic Lipid Accumulation and Inflammation via Regulating miR-34a In VitroInternational Journal of Molecular Sciences 2021; 22(23): 13163 doi: 10.3390/ijms222313163
108
Philip N. Newsome, Kristine Buchholtz, Kenneth Cusi, Martin Linder, Takeshi Okanoue, Vlad Ratziu, Arun J. Sanyal, Anne-Sophie Sejling, Stephen A. Harrison. A Placebo-Controlled Trial of Subcutaneous Semaglutide in Nonalcoholic SteatohepatitisNew England Journal of Medicine 2021; 384(12): 1113 doi: 10.1056/NEJMoa2028395
109
Sevket Balta. Atherosclerosis and Non-Alcoholic Fatty Liver DiseaseAngiology 2022; : 000331972210913 doi: 10.1177/00033197221091317
110
Nuria Perez-Diaz-del-Campo, Bertha Araceli Marin-Alejandre, Irene Cantero, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Jose I. Riezu-Boj, Fermín I. Milagro, Josep A. Tur, J. Alfredo Martinez, Itziar Abete, M. Angeles Zulet. Differential response to a 6-month energy-restricted treatment depending on SH2B1 rs7359397 variant in NAFLD subjects: Fatty Liver in Obesity (FLiO) StudyEuropean Journal of Nutrition 2021; 60(6): 3043 doi: 10.1007/s00394-020-02476-x
111
Marc-Olivier Deguise, Chantal Pileggi, Yves De Repentigny, Ariane Beauvais, Alexandra Tierney, Lucia Chehade, Jean Michaud, Maica Llavero-Hurtado, Douglas Lamont, Abdelmadjid Atrih, Thomas M. Wishart, Thomas H. Gillingwater, Bernard L. Schneider, Mary-Ellen Harper, Simon H. Parson, Rashmi Kothary. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver DiseaseCellular and Molecular Gastroenterology and Hepatology 2021; 12(1): 354 doi: 10.1016/j.jcmgh.2021.01.019
112
Khalid Alswat, Faisal M Sanai, Waleed Al-hamoudi, Mona Ismail, Yaser Dahlan, Hamdan Saleh AlGhamdi, Ibrahim Altraif, Abduljaleel Alalwan, Mohamed MA Babatin, Saleh A Alqahtani. Clinical and Metabolic Characteristics of Non-Alcoholic Fatty Liver Disease Patients in Saudi Arabia: Data from the Systematic Observatory Liver Disease (SOLID) RegistryDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2021; : 1167 doi: 10.2147/DMSO.S300051
113
Yongin Cho, Yong-ho Lee. State-of-the-Art Overview of the Pharmacological Treatment of Non-Alcoholic SteatohepatitisEndocrinology and Metabolism 2022; 37(1): 38 doi: 10.3803/EnM.2022.102
114
Stefano Ballestri, Fabio Nascimbeni, Simonetta Lugari, Amedeo Lonardo, Giampiero Francica. A critical appraisal of the use of ultrasound in hepatic steatosisExpert Review of Gastroenterology & Hepatology 2019; 13(7): 667 doi: 10.1080/17474124.2019.1621164
115
Chayanis Kositamongkol, Thammanard Charernboon, Thanet Chaisathaphol, Chaiwat Washirasaksiri, Chonticha Auesomwang, Tullaya Sitasuwan, Phunchai Charatcharoenwitthaya, Pochamana Phisalprapa. Clinical predictive score for detecting nonalcoholic fatty liver disease with significant fibrosis in patients with metabolic syndromeMedicine 2021; 100(44): e27640 doi: 10.1097/MD.0000000000027640
116
Li‐Wei Chen, Mi‐Sio Huang, Yu‐Chiau Shyu, Rong‐Nan Chien. Gamma‐glutamyl transpeptidase elevation is associated with metabolic syndrome, hepatic steatosis, and fibrosis in patients with nonalcoholic fatty liver disease: A community‐based cross‐sectional studyThe Kaohsiung Journal of Medical Sciences 2021; 37(9): 819 doi: 10.1002/kjm2.12395
117
Mitra Ahadi, Kasra Molooghi, Negin Masoudifar, Ali Beheshti Namdar, Hassan Vossoughinia, Mohammadreza Farzanehfar. A review of non‐alcoholic fatty liver disease in non‐obese and lean individualsJournal of Gastroenterology and Hepatology 2021; 36(6): 1497 doi: 10.1111/jgh.15353
118
Shirley Yuk-Wah Liu, Vincent Wai-Sun Wong, Simon Kin-Hung Wong, Grace Lai-Hung Wong, Carol Man-sze Lai, Candice Chuen-Hing Lam, Sally She-Ting Shu, Henry Lik-Yuen Chan, Enders Kwok-Wai Ng. A prospective 5-year study on the use of transient elastography to monitor the improvement of non-alcoholic fatty liver disease following bariatric surgeryScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-83782-0
119
Igor V Maev, Aleksey A Samsonov, Liudmila K Palgova, Chavdar S Pavlov, Elena Shirokova, Kirill M Starostin. Real-world comorbidities and treatment patterns among patients with non-alcoholic fatty liver disease receiving phosphatidylcholine as adjunctive therapy in RussiaBMJ Open Gastroenterology 2019; 6(1): e000307 doi: 10.1136/bmjgast-2019-000307
120
Hasen A. Al-ghamdi, Fayza F. Al Fayez, Abdulhadi I. Bima, Taghreed M. Khawaji, Ayman Z. Elsamanoudy. Study of Cellular Senescence and Vitamin D Deficiency in Nonalcoholic Fatty Liver Disease and The Potential Protective Effect of Vitamin D SupplementationJournal of Clinical and Experimental Hepatology 2021; 11(2): 219 doi: 10.1016/j.jceh.2020.07.003
121
Javier Vázquez-Bourgon, Víctor Ortiz-García de la Foz, Irene Suarez-Pereira, Paula Iruzubieta, María Teresa Arias-Loste, Esther Setién-Suero, Rosa Ayesa-Arriola, Marcos Gómez-Revuelta, Javier Crespo, Benedicto Crespo Facorro. Cannabis consumption and non-alcoholic fatty liver disease. A three years longitudinal study in first episode non-affective psychosis patientsProgress in Neuro-Psychopharmacology and Biological Psychiatry 2019; 95: 109677 doi: 10.1016/j.pnpbp.2019.109677
122
Vincenza Di Stasi, Elisa Maseroli, Giulia Rastrelli, Irene Scavello, Sarah Cipriani, Tommaso Todisco, Sara Marchiani, Flavia Sorbi, Massimiliano Fambrini, Felice Petraglia, Mario Maggi, Linda Vignozzi. SHBG as a Marker of NAFLD and Metabolic Impairments in Women Referred for Oligomenorrhea and/or Hirsutism and in Women With Sexual DysfunctionFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.641446
123
Xiongfeng Pan, Shi Wu Wen, Atipatsa C. Kaminga, Aizhong Liu. Gut metabolites and inflammation factors in non-alcoholic fatty liver disease: A systematic review and meta-analysisScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-65051-8
124
Priyanka Bhandari, Amit Sapra, Mohitkumar S Ajmeri, Christine E Albers, Devanshika Sapra. Nonalcoholic Fatty Liver Disease: Could It Be the Next Medical Tsunami?Cureus 2022;  doi: 10.7759/cureus.23806
125
Amir Mari, Tawfik Khoury, Helal Said Ahmad, Fadi Abu Baker, Anas Kadah, Wisam Sbeit, Rinaldo Pellicano, Mahmud Mahamid. The association between non-alcoholic fatty liver disease and valvular heart diseaseMinerva Cardioangiologica 2020; 68(1) doi: 10.23736/S0026-4725.19.05087-4
126
Mustafa Al-Karaghouli, Sonia Fuentes, Tracy Davyduke, Mang Ma, Juan G Abraldes. Impact of statin treatment on non-invasive tests based predictions of fibrosis in a referral pathway for NAFLDBMJ Open Gastroenterology 2022; 9(1): e000798 doi: 10.1136/bmjgast-2021-000798
127
Giandomenico Bisaccia, Fabrizio Ricci, Cesare Mantini, Claudio Tana, Gian Luca Romani, Cosima Schiavone, Sabina Gallina. Nonalcoholic fatty liver disease and cardiovascular disease phenotypesSAGE Open Medicine 2020; 8: 205031212093380 doi: 10.1177/2050312120933804
128
Anna Laitakari, Joona Tapio, Kari A. Mäkelä, Karl-Heinz Herzig, Franziska Dengler, Helena Gylling, Gail Walkinshaw, Johanna Myllyharju, Elitsa Y. Dimova, Raisa Serpi, Peppi Koivunen. HIF-P4H-2 inhibition enhances intestinal fructose metabolism and induces thermogenesis protecting against NAFLDJournal of Molecular Medicine 2020; 98(5): 719 doi: 10.1007/s00109-020-01903-0
129
Macarena Ortiz, Sandra A. Soto-Alarcón, Paula Orellana, Alejandra Espinosa, Cristian Campos, Sandra López-Arana, Miguel A. Rincón, Paola Illesca, Rodrigo Valenzuela, Luis A. Videla. Suppression of high-fat diet-induced obesity-associated liver mitochondrial dysfunction by docosahexaenoic acid and hydroxytyrosol co-administrationDigestive and Liver Disease 2020; 52(8): 895 doi: 10.1016/j.dld.2020.04.019
130
Mohammad H. Jamal, Rawan El-Abd. Laparoscopic Sleeve Gastrectomy2021; : 115 doi: 10.1007/978-3-030-57373-7_15
131
Nuria Perez-Diaz-del-Campo, Jose I. Riezu-Boj, Bertha Araceli Marin-Alejandre, J. Ignacio Monreal, Mariana Elorz, José Ignacio Herrero, Alberto Benito-Boillos, Fermín I. Milagro, Josep A. Tur, Itziar Abete, M. Angeles Zulet, J. Alfredo Martinez. Three Different Genetic Risk Scores Based on Fatty Liver Index, Magnetic Resonance Imaging and Lipidomic for a Nutrigenetic Personalized Management of NAFLD: The Fatty Liver in Obesity StudyDiagnostics 2021; 11(6): 1083 doi: 10.3390/diagnostics11061083
132
Ana J. F. C. Aguiar, Jaluza L. C. de Queiroz, Pedro P. A. Santos, Christina S. Camillo, Alexandre C. Serquiz, Izael S. Costa, Gerciane S. Oliveira, Ana F. T. Gomes, Lídia L. R. Matias, Rafael O. A. Costa, Thaís S. Passos, Ana H. A. Morais. Beneficial Effects of Tamarind Trypsin Inhibitor in Chitosan–Whey Protein Nanoparticles on Hepatic Injury Induced High Glycemic Index Diet: A Preclinical StudyInternational Journal of Molecular Sciences 2021; 22(18): 9968 doi: 10.3390/ijms22189968
133
Caroline Chong Nguyen, Denis Duboc, Dominique Rainteau, Harry Sokol, Lydie Humbert, Philippe Seksik, Adèle Bellino, Hendy Abdoul, Naïm Bouazza, Jean-Marc Treluyer, Malika Saadi, Karim Wahbi, Heithem Soliman, Benoit Coffin, André Bado, Maude Le Gall, Olivier Varenne, Henri Duboc. Circulating bile acids concentration is predictive of coronary artery disease in humanScientific Reports 2021; 11(1) doi: 10.1038/s41598-021-02144-y
134
Luke V. Selby, Aslam Ejaz, Stacy A. Brethauer, Timothy M. Pawlik. Fatty liver disease and primary liver cancer: disease mechanisms, emerging therapies and the role of bariatric surgeryExpert Opinion on Investigational Drugs 2020; 29(2): 107 doi: 10.1080/13543784.2020.1721457
135
Jennifer Linge, Mattias Ekstedt, Olof Dahlqvist Leinhard. Adverse muscle composition is linked to poor functional performance and metabolic comorbidities in NAFLDJHEP Reports 2021; 3(1): 100197 doi: 10.1016/j.jhepr.2020.100197
136
Chutian Wu, Yun Zhou, Min Wang, Guolin Dai, Xiongxiu Liu, Leizhen Lai, Shaohui Tang. Bioinformatics Analysis Explores Potential Hub Genes in Nonalcoholic Fatty Liver DiseaseFrontiers in Genetics 2021; 12 doi: 10.3389/fgene.2021.772487
137
Md. Jahangir Alam, Sanjay K. Banerjee. Biochemistry of Cardiovascular Dysfunction in Obesity2020; : 15 doi: 10.1007/978-3-030-47336-5_2
138
Fátima Higuera-de-la-Tijera, Jacqueline Córdova-Gallardo, Elizabeth Buganza-Torio, Beatriz Barranco-Fragoso, Aldo Torre, Sara Parraguirre-Martínez, Martin Edgardo Rojano-Rodríguez, Gabriel Quintero-Bustos, Graciela Castro-Narro, Carlos Moctezuma-Velazquez. Hepamet Fibrosis Score in Nonalcoholic Fatty Liver Disease Patients in Mexico: Lower than Expected Positive Predictive ValueDigestive Diseases and Sciences 2021; 66(12): 4501 doi: 10.1007/s10620-020-06821-2
139
Mohammed Eslam, Shiv K. Sarin, Vincent Wai-Sun Wong, Jian-Gao Fan, Takumi Kawaguchi, Sang Hoon Ahn, Ming-Hua Zheng, Gamal Shiha, Yusuf Yilmaz, Rino Gani, Shahinul Alam, Yock Young Dan, Jia-Horng Kao, Saeed Hamid, Ian Homer Cua, Wah-Kheong Chan, Diana Payawal, Soek-Siam Tan, Tawesak Tanwandee, Leon A. Adams, Manoj Kumar, Masao Omata, Jacob George. The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver diseaseHepatology International 2020; 14(6): 889 doi: 10.1007/s12072-020-10094-2
140
Thomas Marjot, Ahmad Moolla, Jeremy F Cobbold, Leanne Hodson, Jeremy W Tomlinson. Nonalcoholic Fatty Liver Disease in Adults: Current Concepts in Etiology, Outcomes, and ManagementEndocrine Reviews 2020; 41(1): 66 doi: 10.1210/endrev/bnz009
141
Atilla BEKTAS, Meltem ULUSOY, Kemal DAĞALP. URSODEOKSİKOLİK ASİT, DİYABETİK OLMAYAN, ALKOL DIŞI KARACİĞER YAĞLANMASI TEDAVİSİNDE YER ALMALI MI?Konuralp Tıp Dergisi 2020; : 44 doi: 10.18521/ktd.527978
142
Wah‐Kheong Chan, Soek‐Siam Tan, Siew‐Pheng Chan, Yeong‐Yeh Lee, Hoi‐Poh Tee, Sanjiv Mahadeva, Khean‐Lee Goh, Anis Safura Ramli, Feisul Mustapha, Nik Ritza Kosai, Raja Affendi Raja Ali. Malaysian Society of Gastroenterology and Hepatology consensus statement on metabolic dysfunction‐associated fatty liver diseaseJournal of Gastroenterology and Hepatology 2022; 37(5): 795 doi: 10.1111/jgh.15787
143
A.J. Scheen. Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: A common comorbidity associated with severe complicationsDiabetes & Metabolism 2019; 45(3): 213 doi: 10.1016/j.diabet.2019.01.008
144
Yunpeng Gu, Wei Zhang, Yanli Hu, Yutong Chen, Junping Shi. Association between nonalcoholic fatty liver disease and depression: A systematic review and meta-analysis of observational studiesJournal of Affective Disorders 2022; 301: 8 doi: 10.1016/j.jad.2021.12.128
145
Tae Jung Oh, Kyuho Kim, Jae Hoon Moon, Sung Hee Choi, Nam H Cho, Hak Chul Jang. Liver Fibrosis Indices for the Prediction of Mortality in Korean Subjects: A 16-Year Prospective Cohort StudyJournal of the Endocrine Society 2021; 5(10) doi: 10.1210/jendso/bvab123
146
Giulia Besutti, Lisa Bonilauri, Elisa Manicardi, Francesco Venturelli, Efrem Bonelli, Filippo Monelli, Valeria Manicardi, Luca Valenti, Guido Ligabue, Susanna Schianchi, Marco Massari, Nicoletta Riva, Elisabetta Froio, Elena Tagliavini, Pierpaolo Pattacini, Paolo Giorgi Rossi. Feasibility and efficiency of European guidelines for NAFLD assessment in patients with type 2 diabetes: A prospective studyDiabetes Research and Clinical Practice 2021; 177: 108882 doi: 10.1016/j.diabres.2021.108882
147
Maria Lilibeth Manzanilla Valdez, Maira Rubi Segura Campos. Renal and Hepatic Disease: Cnidoscolus aconitifolius as Diet Therapy Proposal for Prevention and TreatmentJournal of the American College of Nutrition 2021; 40(7): 646 doi: 10.1080/07315724.2020.1810171
148
Ron S. Newfield, Carrie L. Graves, Robert O. Newbury, Jeffrey B. Schwimmer, James A. Proudfoot, Daphne S. Say, Ariel E. Feldstein. Non‐alcoholic fatty liver disease in pediatric type 2 diabetes: Metabolic and histologic characteristics in 38 subjectsPediatric Diabetes 2018;  doi: 10.1111/pedi.12798
149
Stergios A. Polyzos, Eun Seok Kang, Chrysoula Boutari, Eun-Jung Rhee, Christos S. Mantzoros. Current and emerging pharmacological options for the treatment of nonalcoholic steatohepatitisMetabolism 2020; 111: 154203 doi: 10.1016/j.metabol.2020.154203
150
Stergios A. Polyzos, Jannis Kountouras, Christos S. Mantzoros. Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeuticsMetabolism 2019; 92: 82 doi: 10.1016/j.metabol.2018.11.014
151
Taisiia Turankova, Oleg Blyuss, Alexey Brazhnikov, Andrey Svistunov, Kurinchi Selvan Gurusamy, Chavdar S Pavlov. Transient elastography with controlled attenuation parameter (CAP) for diagnosis of moderate or severe steatosis in people with suspected non-alcoholic fatty liver diseaseCochrane Database of Systematic Reviews 2020;  doi: 10.1002/14651858.CD013670
152
Qiu-Xuan Li, Han Gao, Yue-Xin Guo, Bo-Ya Wang, Rong-xuan Hua, Lei Gao, Hong-Wei Shang, Xin Lu, Jing-Dong Xu. GLP-1 and Underlying Beneficial Actions in Alzheimer’s Disease, Hypertension, and NASHFrontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.721198
153
Ralitsa Robeva, Dušan Mladenović, Milena Vesković, Dragan Hrnčić, Jelica Bjekić-Macut, Olivera Stanojlović, Sarantis Livadas, Bulent O. Yildiz, Djuro Macut. The interplay between metabolic dysregulations and non-alcoholic fatty liver disease in women after menopauseMaturitas 2021; 151: 22 doi: 10.1016/j.maturitas.2021.06.012
154
Simona Cernea, Itamar Raz. NAFLD in type 2 diabetes mellitus: Still many challenging questions Diabetes/Metabolism Research and Reviews 2021; 37(2) doi: 10.1002/dmrr.3386
155
Manal H. El-Sayed, Rasha A. Thabet, Mohamed T. Hamza, Muhammad S. Hussein, Maha M. El Saeed. Liver disease in children and adolescents with type 1 diabetes mellitus: A link between glycemic control and hepatopathyDiabetes Research and Clinical Practice 2020; 170: 108458 doi: 10.1016/j.diabres.2020.108458
156
Yi-Ning Dai, Cheng-Fu Xu, Hong-Ying Pan, Hai-Jun Huang, Mei-Juan Chen, You-Ming Li, Chao-Hui Yu. Metabolic dysfunction is associated with steatosis but no other histologic features in nonalcoholic fatty liver diseaseWorld Journal of Clinical Cases 2022; 10(13): 4097-4109 doi: 10.12998/wjcc.v10.i13.4097
157
Maya Margalit, Hanny Yeshua, Neta Gotlieb, Shira Zelber-Sagi. NAFLD and NASH2020; : 11 doi: 10.1007/978-3-030-37173-9_2
158
Élise Vuille-Lessard, Naomi Lange, Carlotta Riebensahm, Jean-François Dufour, Annalisa Berzigotti. Dietary Interventions in Liver Diseases: Focus on MAFLD and CirrhosisCurrent Hepatology Reports 2021; 20(2): 61 doi: 10.1007/s11901-021-00563-z
159
Weijie Lin, Zhengrong Liu, Ling Li, Zhiling Zhou, Shiyu Ma, Fazhong He. Effects of Shugan Quzhi Capsule in treating different metabolic diseases based on network pharmacology and molecular docking2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM) 2021; : 3832 doi: 10.1109/BIBM52615.2021.9669290
160
Yan Sun, Nie Zhang, Yun-Long Ding, Li-Jiang Yu, Jun Cai, De Ma, Wu Yang, Wang-Kun Lu, Jia-Li Niu. Effect of lipid metabolism disorder on liver function in patients with malignant tumors after chemotherapy: a case-control studyLipids in Health and Disease 2019; 18(1) doi: 10.1186/s12944-019-1063-y
161
Samy A. Azer, Rana Hasanato. Use of bile acids as potential markers of liver dysfunction in humansMedicine 2021; 100(41): e27464 doi: 10.1097/MD.0000000000027464
162
Carolina Castillo-Castro, Alexandro José Martagón-Rosado, Rocio Ortiz-Lopez, Luis Felipe Garrido-Treviño, Melissa Villegas-Albo, Francisco Javier Bosques-Padilla. Promising diagnostic biomarkers of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: From clinical proteomics to microbiomeWorld Journal of Hepatology 2021; 13(11): 1494-1511 doi: 10.4254/wjh.v13.i11.1494
163
Amedeo Lonardo. Metabolomic signature: one step forward in the process of obtaining NAFLD patients’ metabolic identity cardThe American Journal of Clinical Nutrition 2022; 115(3): 603 doi: 10.1093/ajcn/nqab399
164
Joanna Michałowska, Ewa Miller-Kasprzak, Paweł Bogdański. Incretin Hormones in Obesity and Related Cardiometabolic Disorders: The Clinical PerspectiveNutrients 2021; 13(2): 351 doi: 10.3390/nu13020351
165
Nancy de los Ángeles Segura-Azuara, Carlos Daniel Varela-Chinchilla, Plinio A. Trinidad-Calderón. MAFLD/NAFLD Biopsy-Free Scoring Systems for Hepatic Steatosis, NASH, and Fibrosis DiagnosisFrontiers in Medicine 2022; 8 doi: 10.3389/fmed.2021.774079
166
Muhammad Usman, Nabiyah Bakhtawar. Vitamin E as an Adjuvant Treatment for Non-alcoholic Fatty Liver Disease in Adults: A Systematic Review of Randomized Controlled Trials Cureus 2020;  doi: 10.7759/cureus.9018
167
Duanghathai Pasanta, Khin Thandar Htun, Jie Pan, Montree Tungjai, Siriprapa Kaewjaeng, Hongjoo Kim, Jakrapong Kaewkhao, Suchart Kothan. Magnetic Resonance Spectroscopy of Hepatic Fat from Fundamental to Clinical ApplicationsDiagnostics 2021; 11(5): 842 doi: 10.3390/diagnostics11050842
168
Guoyan Jiang, Chunhong Sun, Xiaodong Wang, Jie Mei, Chen Li, Honghong Zhan, Yixuan Liao, Yongjun Zhu, Jingxin Mao. Hepatoprotective mechanism of Silybum marianum on nonalcoholic fatty liver disease based on network pharmacology and experimental verificationBioengineered 2022; 13(3): 5216 doi: 10.1080/21655979.2022.2037374
169
Julia Teck. Diabetes-Associated ComorbiditiesPrimary Care: Clinics in Office Practice 2022; 49(2): 275 doi: 10.1016/j.pop.2021.11.004
170
Hüseyin Vural, Ferah Armutcu, Omer Akyol, Ralf Weiskirchen. The potential pathophysiological role of altered lipid metabolism and electronegative low-density lipoprotein (LDL) in non-alcoholic fatty liver disease and cardiovascular diseasesClinica Chimica Acta 2021; 523: 374 doi: 10.1016/j.cca.2021.10.018
171
Yahya Pasdar, Farhad Oubari, Mahin Nikougoftar Zarif, Mehrnaz Abbasi, Azizollah Pourmahmoudi, Mahboobe Hosseinikia. Effects of Quercetin Supplementation on Hematological Parameters in Non-Alcoholic Fatty Liver Disease: a Randomized, Double-Blind, Placebo-Controlled Pilot StudyClinical Nutrition Research 2020; 9(1): 11 doi: 10.7762/cnr.2020.9.1.11
172
Samar H. Gerges, Sara A. Wahdan, Doaa A. Elsherbiny, Ebtehal El-Demerdash. Non-alcoholic fatty liver disease: An overview of risk factors, pathophysiological mechanisms, diagnostic procedures, and therapeutic interventionsLife Sciences 2021; 271: 119220 doi: 10.1016/j.lfs.2021.119220
173
Rohitash Jamwal, Benjamin J. Barlock. Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) EnzymesPharmaceuticals 2020; 13(9): 222 doi: 10.3390/ph13090222
174
Ming Li, Qian Wang, Yong Li, Shengtian Cao, Yingjun Zhang, Zhongqing Wang, Guozhu Liu, Jing Li, Baohua Gu. Apical sodium-dependent bile acid transporter, drug target for bile acid related diseases and delivery target for prodrugs: Current and future challengesPharmacology & Therapeutics 2020; 212: 107539 doi: 10.1016/j.pharmthera.2020.107539
175
L.V. Zhuravlyova, O.V. Elhaj. THE ROLE OF RESISTIN IN THE PROGRESSION OF NON-ALCOHOLIC FATTY LIVER DISEASEInter Collegas 2021; 8(3): 157 doi: 10.35339/ic.8.3.157-162
176
Carlos Benítez, Juan Pablo Arab, Francisco Barrera, Jesus M. Banales, Marco Arrese. NAFLD and NASH2020; : 225 doi: 10.1007/978-3-030-37173-9_13
177
D. Yu. Venidiktova, A. V. Borsukov. Non-drug treatment of non-alcoholic fatty liver disease: evaluation of effectiveness with ultrasound steatometryMedical alphabet 2020; (10): 38 doi: 10.33667/2078-5631-2020-10-38-42
178
Mingshan Guo, Qianyu Pan, Xiaojin Shi, W. Du, S. Grasso. The Comparison and Contrast on NAFLD between the East and the West: Metabolic Mechanism, Dietary Habits, and PoliciesE3S Web of Conferences 2021; 308: 02021 doi: 10.1051/e3sconf/202130802021
179
Eira Cerda-Reyes, Alicia Sarahi Ojeda-Yuren, Julián Torres-Vazquez, María del Rosario Herrero Maceda, Martín Uriel Vázquez-Medina, Perla Denice Flores-Rangel, Yailin Fabiola Velásquez Palacios, Saraid Cerda-Reyes, Graciela Elia Castro-Narro. Advances in Hepatology2021;  doi: 10.5772/intechopen.96281
180
Danielle Chi, Meghan Burk. What You Should Know About Fatty Liver DiseaseADCES in Practice 2020; 8(4): 34 doi: 10.1177/2633559X20928918
181
Bernardo Stefanini, Matteo Tonnini, Ilaria Serio, Matteo Renzulli, Francesco Tovoli. Surveillance for hepatocellular carcinoma: current status and future perspectives for improvementExpert Review of Anticancer Therapy 2022; 22(4): 371 doi: 10.1080/14737140.2022.2052276
182
Tony (Dazhong) Huang, Jason Behary, Amany Zekry. Non‐alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and managementInternal Medicine Journal 2020; 50(9): 1038 doi: 10.1111/imj.14709
183
Valentin Blank, David Petroff, Sebastian Beer, Albrecht Böhlig, Maria Heni, Thomas Berg, Yvonne Bausback, Arne Dietrich, Anke Tönjes, Marcus Hollenbach, Matthias Blüher, Volker Keim, Johannes Wiegand, Thomas Karlas. Current NAFLD guidelines for risk stratification in diabetic patients have poor diagnostic discriminationScientific Reports 2020; 10(1) doi: 10.1038/s41598-020-75227-x
184
Rasika Pradeep Herath, Shirom R. Siriwardana, Chanil D. Ekanayake, Vikum Abeysekara, Sajith U. A. Kodithuwakku, Himali P. Herath, Jonathan M. Peterson. Non-alcoholic fatty liver disease and pregnancy complications among Sri Lankan women: A cross sectional analytical studyPLOS ONE 2019; 14(4): e0215326 doi: 10.1371/journal.pone.0215326
185
Sarah Theurer, Julia Kälsch, Suzan Schwertheim, Simone Kathemann, Hideo A. Baba. Histopathologische Diagnostik und Differenzialdiagnostik der nichtalkoholischen FettlebererkrankungDer Pathologe 2020; 41(5): 434 doi: 10.1007/s00292-020-00800-0
186
Jia-Zhen Zhang, Jing-Jing Cai, Yao Yu, Zhi-Gang She, Hongliang Li. Nonalcoholic Fatty Liver Disease: An Update on the DiagnosisGene Expression 2019; 19(3): 187 doi: 10.3727/105221619X15553433838609
187
Jia Han, Xin Guo, Tomoyuki Koyama, Daichi Kawai, Jing Zhang, Reimon Yamaguchi, Xiaolei Zhou, Yoshiharu Motoo, Takumi Satoh, Sohsuke Yamada. Zonarol Protected Liver from Methionine- and Choline-Deficient Diet-Induced Nonalcoholic Fatty Liver Disease in a Mouse ModelNutrients 2021; 13(10): 3455 doi: 10.3390/nu13103455
188
Yan Li, Chunyi Wang, Yu Jin, Haibo Chen, Meiqun Cao, Weimin Li, Huanmin Luo, Zhengzhi Wu. Huang-Qi San improves glucose and lipid metabolism and exerts protective effects against hepatic steatosis in high fat diet-fed ratsBiomedicine & Pharmacotherapy 2020; 126: 109734 doi: 10.1016/j.biopha.2019.109734
189
Qing Gu, Li Cen, Jiawei Lai, Zhongchen Zhang, Jiaqi Pan, Feng Zhao, Chaohui Yu, Youming Li, Chunxiao Chen, Weixing Chen, Zhe Shen. A meta‐analysis on the diagnostic performance of magnetic resonance imaging and transient elastography in nonalcoholic fatty liver diseaseEuropean Journal of Clinical Investigation 2021; 51(2) doi: 10.1111/eci.13446
190
Jun Noichi, Tomoko Ishiakawa, Ikuyo Ichi, Yoko Fujiwara. Effect of tocotrienol on the primary progression of nonalcoholic steatohepatitis in a mouse modelJournal of Clinical Biochemistry and Nutrition 2022; 70(2): 140 doi: 10.3164/jcbn.21-69
191
Pierpaolo Pellicori, Muthiah Vaduganathan, João Pedro Ferreira, Faiez Zannad, Arun J. Sanyal. Cross-talk between non-alcoholic fatty liver disease and cardiovascular disease: implications for future trial designDiabetes & Metabolism 2022; 48(2): 101281 doi: 10.1016/j.diabet.2021.101281
192
Dimitrios A. Koutoukidis, Constantinos Koshiaris, John A. Henry, Michaela Noreik, Elizabeth Morris, Indrani Manoharan, Kate Tudor, Emma Bodenham, Anna Dunnigan, Susan A. Jebb, Paul Aveyard. The effect of the magnitude of weight loss on non-alcoholic fatty liver disease: A systematic review and meta-analysisMetabolism 2021; 115: 154455 doi: 10.1016/j.metabol.2020.154455
193
Haiyan Liu, Jie Xu, Hui Li, Lina Zhang, Pingzhen Xu. Network pharmacology‐based investigation to explore the effect and mechanism of Erchen decoction against the nonalcoholic fatty liver diseaseThe Anatomical Record 2021; 304(11): 2605 doi: 10.1002/ar.24770
194
Kavita Garg, Scott Brackett, Irl B. Hirsch, Satish K. Garg. NAFLD/NASH and DiabetesDiabetes Technology & Therapeutics 2020; 22(S1): S-174 doi: 10.1089/dia.2020.2513
195
Wanlu Su, Yuxia Wang, Kang Chen, Jie Wang, Anping Wang, Xulei Tang, Li Yan, Zuojie Luo, Guijun Qin, Lulu Chen, Guang Ning, Yiming Mu. Association between nonalcoholic fatty liver and increased low‐level albuminuria in postmenopausal women in China: A cross‐sectional study Journal of Diabetes 2021; 13(6): 494 doi: 10.1111/1753-0407.13134
196
Feng-Zhi Xin, Ze-Hua Zhao, Rui-Nan Zhang, Qin Pan, Zi-Zhen Gong, Chao Sun, Jian-Gao Fan. Folic acid attenuates high-fat diet-induced steatohepatitis <i>via</i> deacetylase SIRT1-dependent restoration of PPARαWorld Journal of Gastroenterology 2020; 26(18): 2203-2220 doi: 10.3748/wjg.v26.i18.2203
197
L. B. Lazebnik, E. V. Golovanova, S. V. Turkina, K. L. Raikhelson, S. V. Okovityy, O. M. Drapkina, I. V. Maev, A. I. Martynov, G. E. Roitberg, O. V. Khlynova, D. I. Abdulganieva, S. A. Alekseenko, M. D. Ardatskaya, I. G. Bakulin, N. V. Bakulina, A. O. Bueverov, E. V. Vinitskaya, G. V. Volynets, E. Yu. Eremina, V. B. Grinevich, A. I. Dolgushina, A. N. Kazyulin, E. I. Kashkina, I. V. Kozlova, Yu. V. Konev, N. V. Korochanskaya, Yu. A. Kravchuk, E. D. Li, I. D. Loranskaya, V. M. Makhov, S. N. Mekhtiev, V. P. Novikova, O. D. Ostroumova, Ch. S. Pavlov, V. G. Radchenko, A. A. Samsonov, A. S. Sarsenbaeva, R. G. Sayfutdinov, P. V. Seliverstov, S. I. Sitkin, O. V. Stefanyuk, L. V. Tarasova, E. I. Tkachenko, Yu. P. Uspensky, Yu. A. Fominykh, A. I. Khavkin, Yu. V. Tsyganova, O. O. Sharhun. Non-alcoholic fatty liver disease in adults: clinic, diagnostics, treatment. Guidelines for therapists, third versionExperimental and Clinical Gastroenterology 2021; 1(1): 4 doi: 10.31146/1682-8658-ecg-185-1-4-52
198
Michelle Saoi, Kazunori Sasaki, Hitoshi Sagawa, Kaori Abe, Tomomi Kogiso, Katsutoshi Tokushige, Etsuko Hashimoto, Yoshiaki Ohashi, Philip Britz-McKibbin. High Throughput Screening of Serum γ-Glutamyl Dipeptides for Risk Assessment of Nonalcoholic Steatohepatitis with Impaired Glutathione Salvage PathwayJournal of Proteome Research 2020; 19(7): 2689 doi: 10.1021/acs.jproteome.9b00405
199
Elissa Lin, Aaron Justin Yeoh, Violeta Popov. Nutrition, Weight, and Digestive Health2022; : 207 doi: 10.1007/978-3-030-94953-2_13
200
Amélio F. Godoy-Matos, Wellington S. Silva Júnior, Cynthia M. Valerio. NAFLD as a continuum: from obesity to metabolic syndrome and diabetesDiabetology & Metabolic Syndrome 2020; 12(1) doi: 10.1186/s13098-020-00570-y
201
Emily Brown, T. Hydes, A. Hamid, D.J. Cuthbertson. Emerging and Established Therapeutic Approaches for Nonalcoholic Fatty Liver DiseaseClinical Therapeutics 2021; 43(9): 1476 doi: 10.1016/j.clinthera.2021.07.013
202
Ja-Young Kwon. Non-alcoholic fatty liver disease in pregnancy, paving the way for adverse pregnancy outcome risk assessmentClinical and Molecular Hepatology 2022; 28(1): 50 doi: 10.3350/cmh.2021.0359
203
Nick Finer. Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomesDiabetes, Obesity and Metabolism 2022; 24(S2): 44 doi: 10.1111/dom.14569
204
Shih-Chieh Shao, Liang-Tseng Kuo, Rong-Nan Chien, Ming-Jui Hung, Edward Chia-Cheng Lai. SGLT2 inhibitors in patients with type 2 diabetes with non-alcoholic fatty liver diseases: an umbrella review of systematic reviewsBMJ Open Diabetes Research & Care 2020; 8(2): e001956 doi: 10.1136/bmjdrc-2020-001956
205
Eirini Martinou, Marinos Pericleous, Irena Stefanova, Vasha Kaur, Angeliki M. Angelidi. Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive ApproachesDiagnostics 2022; 12(2): 407 doi: 10.3390/diagnostics12020407
206
Jae Young Choi, Tae-Woo Jang, Phil Hyun Song, Seong Hoon Choi, Sae-Kwang Ku, Chang-Hyun Song. Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in MiceAntioxidants 2022; 11(3): 580 doi: 10.3390/antiox11030580
207
Mohammad Bagher Majnooni, Mari Ataee, Gholamreza Bahrami, Fatemeh Heydarpour, Ina Yosifova Aneva, Mohammad Hosein Farzaei, Touraj Ahmadi‐Juoibari. The effects of co‐administration of artichoke leaf extract supplementation with metformin and vitamin E in patients with nonalcoholic fatty liver disease: A randomized clinical trialPhytotherapy Research 2021; 35(11): 6324 doi: 10.1002/ptr.7279
208
Dariusz Narankiewicz, Josefina Ruiz-Nava, Veronica Buonaiuto, María Isabel Ruiz-Moreno, María Dolores López-Carmona, Luis Miguel Pérez-Belmonte, Ricardo Gómez-Huelgas, María Rosa Bernal-López. Utility of Liver Function Tests and Fatty Liver Index to Categorize Metabolic Phenotypes in a Mediterranean PopulationInternational Journal of Environmental Research and Public Health 2020; 17(10): 3518 doi: 10.3390/ijerph17103518
209
David S. Mathiesen, Asger Lund, Tina Vilsbøll, Filip K. Knop, Jonatan I. Bagger. Amylin and Calcitonin: Potential Therapeutic Strategies to Reduce Body Weight and Liver FatFrontiers in Endocrinology 2021; 11 doi: 10.3389/fendo.2020.617400
210
Laura Antonucci, Cristiana Porcu, Eleonora Timperi, Silvano Junior Santini, Gino Iannucci, Clara Balsano. Circulating Neutrophils of Nonalcoholic Steatohepatitis Patients Show an Activated Phenotype and Suppress T Lymphocytes ActivityJournal of Immunology Research 2020; 2020: 1 doi: 10.1155/2020/4570219
211
Monica Lupsor-Platon, Teodora Serban, Alexandra Iulia Silion, George Razvan Tirpe, Alexandru Tirpe, Mira Florea. Performance of Ultrasound Techniques and the Potential of Artificial Intelligence in the Evaluation of Hepatocellular Carcinoma and Non-Alcoholic Fatty Liver DiseaseCancers 2021; 13(4): 790 doi: 10.3390/cancers13040790